Form4insider filings, from the source

SEC Form 4 · accession 0001209191-15-067017

Atara Biotherapeutics, Inc. · ATRA

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Gad Soffer
Officer — Chief Operating Officer
Period of report
Aug 17, 2015
Accepted (ET)
Aug 19, 2015 · 8:37 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001604464

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF1Aug 17, 2015M9,615$0.00A75,403D
Common StockF1Aug 17, 2015M4,145$0.00A79,548D
Common StockAug 17, 2015M2,778$11.00A82,326D
Common StockAug 17, 2015S8,778$50.00D73,548D
Common StockF3Aug 18, 2015S4,284$49.26D69,264D
Common StockF5Aug 18, 2015S3,427$49.78D65,837D

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Restricted Stock UnitsF6,F7,F8—Aug 17, 2015M9,615D——Common Stock9,61564,103D
Restricted Stock UnitsF6,F9,F10—Aug 17, 2015M4,145D——Common Stock4,14540,076D
Employee Stock Option (Right to Buy)F11$11.00Aug 17, 2015M2,778D—Oct 24, 2021Common Stock2,77837,222D

Explanation of responses